Results 31 to 40 of about 238,371 (341)

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study [PDF]

, 2018
Aims: To test the prognostic value of emerging biomarkers in the Reduction of Events by Darbepoetin Alfa in Heart Failure (RED-HF) trial. Methods and results: Circulating cardiac [N-terminal pro-B-type natriuretic peptide (NT-proBNP), and high ...
Alehagen, Arimoto, Balling, Bolignano, Cabassi, Dupont, Gaggin, Gravning, Grodin, Guisado Espartero, Haehling, Harrell, Jackson, Lassus, Lassus, Lok, Maisel, Maisel, McMurray, McMurray, Miller, Miller, Nagarajan, Park, Pascual-Figal, Pencina, Pencina, Pocock, Ponikowski, Rahimi, Rush, Shlipak, Swedberg, Tentzeris, Zamora   +34 more
core   +4 more sources

NT‐proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure

Clinical pharmacology and therapy, 2021
N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) is a well‐established biomarker in heart failure (HF) but controversially discussed as a potential surrogate marker in HF trials.
W. Schmitt, H. Rühs, R. Burghaus, Christian Diedrich, Sulav Duwal, T. Eissing, D. Garmann, M. Meyer, B. Ploeger, J. Lippert   +9 more
semanticscholar   +1 more source

Prediction of cardiovascular disease risk by cardiac biomarkers in 2 United Kingdom cohort studies: does utility depend on risk thresholds for treatment? [PDF]

, 2016
We tested the predictive ability of cardiac biomarkers N-terminal pro B-type natriuretic peptide (NT-proBNP), high-sensitivity troponin T, and midregional pro adrenomedullin for cardiovascular disease (CVD) events using the British Regional Heart Study ...
Hart, Carole, McConnachie, Alex, Murray, Heather, Papacosta, Olia, Preiss, David, Ramsay, Sheena, Sattar, Naveed, Upton, Mark, Wannamethee, Goya, Watt, Graham, Welsh, Paul, Whincup, Peter   +11 more
core   +1 more source

N-terminal proBrain Natriuretic Peptide as Indicator of Left Ventricle Hypertrophy In Hypertensive Patients Compared with Left Ventricle Mass Index in Echocardiography

Majalah Kardiologi Indonesia, 2013
Background: Some research reports the usefulness of the N-terminal proBrain natriuretic peptide (NT proBNP) as a diagnostic tool for left ven-tricular hypertrophy due to increased levels of NT proBNP in hypertensive patients with left ventricular ...
Mohammad Ariful Munir, Djanggan Sargowo
doaj   +1 more source

ST2 in Stable and Unstable Ischemic Heart Diseases [PDF]

, 2015
Circulating suppression of tumorigenicity 2 (ST2) predicts cardiovascular outcomes and mortality in ischemic heart disease (IHD). ST2 does not correlate with traditional risk indicators as closely as N-terminal pro–brain natriuretic peptide (NT-proBNP ...
DI SOMMA, Salvatore, Mueller, T., Richards, Am   +2 more
core   +1 more source

N-Terminal Pro–B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study [PDF]

, 2018
Background Contemporary reconsideration of diagnostic N-terminal pro–B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed.
Chen-Tournoux, Annabel A., Christenson, Robert H., Doros, Gheorghe, Gaggin, Hanna K., Hollander, Judd E., Januzzi, James L., Levy, Phillip D., Nagurney, John T., Nowak, Richard M., Pang, Peter S., Patel, Darshita, Peacock, W. Franklin, Rivers, E. Joy, Walters, Elizabeth L.   +13 more
core   +1 more source

Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction

Circulation: Heart Failure, 2020
Supplemental Digital Content is available in the text. Background: Both BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro B-type natriuretic peptide) are widely used to aid diagnosis, assess the effect of therapy, and predict outcomes in ...
R. Rørth, P. Jhund, M. Yılmaz, S. Kristensen, P. Welsh, Akshay S. Desai, L. Køber, M. Prescott, J. Rouleau, S. Solomon, K. Swedberg, M. Zile, M. Packer, J. McMurray   +13 more
semanticscholar   +1 more source

Obesity and Serial NT‐proBNP Levels in Guided Medical Therapy for Heart Failure With Reduced Ejection Fraction: Insights From the GUIDE‐IT Trial

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021
Background Obese patients have lower NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) levels. The prognostic implications of achieving NT‐proBNP levels ≤1000 pg/mL in obese patients with heart failure (HF) receiving biomarker‐guided therapy are not ...
V. Parcha, Nirav Patel, R. Kalra, S. Suri, G. Arora, Thomas J. Wang, P. Arora   +6 more
semanticscholar   +1 more source

Pro-BNP Levels and Its Prognostic Role in Chronic Hypertensive Pregnancies: A Prospective Case-Control Study From A Tertiary Care Hospital

Hypertension in Pregnancy, 2021
Background: This study aimed to investigate the prognostic value of N-terminal B-type natriuretic peptide (NT-proBNP) in pregnancies with isolated chronic hypertension (HT).
Mehmet Akif Erdol, Atakan Tanacan, Hasan Eroglu, Nazan Vanli Tonyali, Mehmet Erdogan, Aykan Yucel, Nuray Yazihan, Dilek Sahin   +7 more
doaj   +1 more source

Exploring the relation between changes in NT-proBNP and renal function in patients with suspected heart failure using structural equation modelling [PDF]

, 2017
Background: The relation between changes in NT-proBNP and renal function has commonly been studied using multiple regressions, which may ignore the complexity of relations between related variables.
Amir, Anand, Andrew L. Clark, Anwaruddin, Bay, Bentler, Christensen, Cleland, Das, DeFilippi, Eggers, Haglin, Hendrix, Hildebrandt, Hoyle, John G.F. Cleland, Jufen Zhang, Kenneth Y-K. Wong, Kistorp, Krauser, Lam, Maisel, Manzano-Fernandez, McCullough, Miller, Pfister, Pfister, Srisawasdi, Stage, Steiger, van Kimmenade, Vickery   +31 more
core   +3 more sources